The authors described the isolation and characterization of a fully human monoclonal antibody for Hepatitis B Virus (HBV). This HuMab was isolated by a combinatorial screen of the memory B-cell repertoire from an acute/recovered HBV-infected patient.
[NPJ Vaccines]